Related Experiment Videos
Diagnostic considerations in juvenile parkinsonism
Dominic C Paviour1, Robert A H Surtees, Andrew J Lees
1National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.
Movement Disorders : Official Journal of the Movement Disorder Society
|February 24, 2004
Summary
Juvenile parkinsonism (JP) is rare, often linked to parkin gene mutations and responding well to levodopa. Other causes usually involve additional neurological signs, making idiopathic Parkinson's disease in youth exceptionally uncommon.
Area of Science:
- Neurology
- Genetics
- Pediatric Medicine
Background:
- Juvenile parkinsonism (JP) presents parkinsonism symptoms before age 21.
- Autosomal recessive juvenile parkinsonism (AR-JP) is frequently associated with parkin gene mutations and levodopa responsiveness.
- Most JP cases, excluding parkin mutations and dopa-responsive dystonia, exhibit additional neurological deficits beyond the basal ganglia.
Purpose of the Study:
- To summarize the current understanding of juvenile parkinsonism.
- To differentiate between genetic and idiopathic forms of JP.
- To highlight the rarity of idiopathic Parkinson's disease in juvenile patients.
Main Methods:
- Literature review of reported juvenile parkinsonism cases.
- Analysis of genetic mutations associated with JP.
- Review of clinical presentations and pathological findings.
Main Results:
- A significant subset of JP cases are AR-JP, caused by parkin gene mutations.
- Levodopa responsiveness is a key indicator for AR-JP.
- Idiopathic Parkinson's disease with Lewy body pathology is exceedingly rare in the juvenile population, with only one reported case.
Conclusions:
- Genetic factors, particularly parkin gene mutations, are primary drivers of juvenile parkinsonism.
- The presence of additional neurological signs often points to non-idiopathic causes.
- Idiopathic juvenile Parkinson's disease is exceptionally rare, challenging traditional etiological assumptions for early-onset parkinsonism.